A detailed history of Verition Fund Management LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 29,544 shares of EBS stock, worth $267,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,544
Holding current value
$267,668
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.86 - $6.98 $54,951 - $206,217
29,544 New
29,544 $201,000
Q3 2023

Nov 14, 2023

BUY
$3.17 - $7.91 $174,083 - $434,385
54,916 Added 357.57%
70,274 $238,000
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.21 $112,881 - $202,879
15,358 New
15,358 $112,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $452M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.